Biology-guided adaptive radiotherapy (BiGART) – more than a vision?

References

• Grau C, Hoyer M, Lindegaard J, Overgaard J. The emerging evidence for stereotactic body radiotherapy. Acta Oncol 2006;45:771–4.
   PubMed Web of Science ®Google Scholar
• Grau C, Muren LP, Hoyer M, Lindegaard J, Overgaard J. Image-guided adaptive radiotherapy – integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182–5.
   PubMed Web of Science ®Google Scholar
• Muren LP, Petersen JB, Hansen J, Hafslund R. Medical physics in the Nordic countries: The past, the present and the future. Acta Oncol 2009;48:165–8.
   PubMed Web of Science ®Google Scholar
• Grau C, Olsen DR, Overgaard J, Hoyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy – presence or future?. Acta Oncol 2010;49:884–7.
   PubMed Web of Science ®Google Scholar
• Muren LP, Rossi C, Hug E, Lee A, Glimelius B. Establishing and expanding the indications for proton and particle therapy. Acta Oncol 2013;52:459–62.
   PubMed Web of Science ®Google Scholar
• Winther M. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer. Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncol 2010;49:888–94.
   PubMed Web of Science ®Google Scholar
• Toustrup K, Sorensen BS, Lassen P, Wiuf C, Alsner J, Overgaard J, et al. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. Radiother Oncol 2012;102:122–9.
   PubMed Web of Science ®Google Scholar
• Busk M. PET imaging of tumor hypoxia using 18F labeled pimonidazole. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Malinen E. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Nielsen T. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Partridge M, Yamamoto T, Grau C, Hoyer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997–1011.
   PubMed Web of Science ®Google Scholar
• Mortensen LS, Johansen J, Kallehauge J, Primdahl H, Busk M, Lassen P, et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial. Radiother Oncol 2012;105:14–20.
   PubMed Web of Science ®Google Scholar
• Ardenkjaer-Larsen JH. Magnetic resonance imaging of tumor oxygenation and metabolic profile. Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Thor M, Petersen JB, Bentzen L, Hoyer M, Muren LP. Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer. Acta Oncol 2011;50:918–25.
   PubMed Web of Science ®Google Scholar
• Malinen E, Rodal J, Knudtsen IS, Sovik A, Skogmo HK. Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT. Acta Oncol 2011;50:873–82.
   PubMed Web of Science ®Google Scholar
• Munck Af Rosenschold P, Engelholm S, Ohlhues L, Law I, Vogelius I, Engelholm SA. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol 2011;50:777–83.
   PubMed Web of Science ®Google Scholar
• Andersen EKF, Kristensen GB, Lyng HD, Malinen E. Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers. Acta Oncol 2011;50:859–65.
   PubMed Web of Science ®Google Scholar
• Maggio A, Fiorino C, Mangili P, Cozzarini C, de Cobelli F, Cattaneo GM, et al. Feasibility of safe ultra-high (EQD(2)> 100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by helical tomotherapy. Acta Oncol 2011;50: 25–34.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Uhrdin J, Antonovic L, Dasu A, Nuyts S, Dirix P, et al. Dose prescription and treatment planning based on FMISO-PET hypoxia. Acta Oncol 2012;51:222–30.
   PubMed Web of Science ®Google Scholar
• Nyeng TB, Kallehauge JF, Hoyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol 2011;50:897–907.
   PubMed Web of Science ®Google Scholar
• Palma DA, de Koste JRV, Verbakel W, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50:509–17.
   PubMed Web of Science ®Google Scholar
• De Ruysscher DSH, Defraene G, Kerns SL, Christiaens M, De Ruyck K. Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics. Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
   PubMed Web of Science ®Google Scholar
• Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, et al. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer. Acta Oncol 2011;50:772–6.
   PubMed Web of Science ®Google Scholar
• Knudtsen IS, Rodal J, Brustugun OT, Helland A, Skretting A, Malinen E. Dynamic respiratory gated (18)FDG-PET of lung tumors – a feasibility study. Acta Oncol 2011;50: 889–96.
   PubMed Web of Science ®Google Scholar
• Andersen ES, Muren LP, Sorensen TS, Noe KO, Thor M, Petersen JB, et al. Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer. Phys Med Biol 2012;57:7089–100.
   PubMed Web of Science ®Google Scholar
• Thor M, Bentzen L, Hysing LB, Ekanger C, Helle SI, Karlsdottir A, et al. Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions. Radiother Oncol 2013; 107:147–52.
   PubMed Web of Science ®Google Scholar
• Fellin F, Azzeroni R, Maggio A, Lorentini S, Cozzarini C, Di Muzio N, et al. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: A treatment planning comparison. Radiother Oncol 2013;107:207–12.
   PubMed Web of Science ®Google Scholar
• Moller DS, Khalil AA, Knap MM, Muren LP, Hoffmann L. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients. Acta Oncol 2011;50:883–8.
   PubMed Web of Science ®Google Scholar
• Maggiulli E, Fiorino C, Passoni P, Broggi S, Gianolini S, Salvetti C, et al. Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: Implications for adaptive dose escalation strategies. Acta Oncol 2012;51:318–24.
   PubMed Web of Science ®Google Scholar
• Fledelius W, Keall PJ, Cho BC, Yang XH, Morf D, Scheib S, et al. Tracking latency in image-based dynamic MLC tracking with direct image access. Acta Oncol 2011;50:952–9.
   PubMed Web of Science ®Google Scholar
• Ravkilde T, Keall PJ, Hojbjerre K, Fledelius W, Worm E, Poulsen PR. Geometric accuracy of dynamic MLC tracking with an implantable wired electromagnetic transponder. Acta Oncol 2011;50:944–51.
   PubMed Web of Science ®Google Scholar
• Skyt PS, Petersen JBB, Yates ES, Poulsen PR, Ravkilde TL, Balling P, Muren LP, et al. Dosimetric verification 1 of complex radiotherapy with a 3D optically based dosimetry system: Dose painting and target tracking. Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Nystrom H, Blomqvist E, Hoyer M, Montelius A, Muren LP, Nilsson P, et al. Particle therapy – a next logical step in the improvement of radiotherapy. Acta Oncol 2011;50:741–4.
   PubMed Web of Science ®Google Scholar
• Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–50.
   PubMed Web of Science ®Google Scholar
• Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncol 2011;50:745–56.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li ZF. Proton therapy for head and neck cancer: Rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol 2011; 50:763–71.
   PubMed Web of Science ®Google Scholar
• Thornqvist S, Muren LP, Bentzen L, Hysing LB, Hoyer M, Grau C, et al. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol 2013;52:521–7.
   PubMed Web of Science ®Google Scholar
• Combs S. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Combs S. Treatment with heavy charged particles: Systematic review of results of clinical data and current clinical (comparative) trials. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Schwartz DL, Garden AS, Shah SJ, Chronowski G, Sejpal S, Rosenthal DI, et al. Adaptive radiotherapy for head and neck cancer – Dosimetric results from a prospective clinical trial. Radiother Oncol 2013;106:80–4.
   PubMed Web of Science ®Google Scholar
• Meijer GJ, van der Toorn PP, Bal M, Schuring D, Weterings J, de Wildt M. High precision bladder cancer irradiation by integrating a library planning procedure of 6 prospectively generated SIB IMRT plans with image guidance using lipiodol markers. Radiother Oncol 2012;105:174–9.
   PubMed Web of Science ®Google Scholar
• Nijkamp J, Marijnen C, van Herk M, van Triest B, Sonke JJ. Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer. Radiother Oncol 2012;103: 353–9.
   PubMed Web of Science ®Google Scholar
• Madani I, Duprez F, Boterberg T, Van de Wiele C, Bonte K, Deron P, et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother Oncol 2011;101:351–5.
   PubMed Web of Science ®Google Scholar
• Castadot P, Geets X, Lee JA, Gregoire V. Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: Is the gain in dose distribution worth the effort?. Radiother Oncol 2011;101:343–50.
   PubMed Web of Science ®Google Scholar
• Simone CB, 2nd, Ly D, Dan TD, Ondos J, Ning H, Belard A, et al. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol 2011;101:376–82.
   PubMed Web of Science ®Google Scholar
• Tuomikoski L, Collan J, Keyrilainen J, Visapaa H, Saarilahti K, Tenhunen M. Adaptive radiotherapy in muscle invasive urinary bladder cancer – An effective method to reduce the irradiated bowel volume. Radiother Oncol 2011;99:61–6.
   PubMed Web of Science ®Google Scholar
• Murthy V, Master Z, Adurkar P, Mallick I, Mahantshetty U, Bakshi G, et al. ‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol 2011;99:55–60.
   PubMed Web of Science ®Google Scholar
• Elstrom UV, Wysocka BA, Muren LP, Petersen JB, Grau C. Daily kV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncol 2010;49:1101–8.
   PubMed Web of Science ®Google Scholar
• Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Radiation dose response of normal lung assessed by cone beam CT – A potential tool for biologically adaptive radiation therapy. Radiother Oncol 2011;100:351–5.
   PubMed Web of Science ®Google Scholar
• Lykkegaard Schmidt M. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Verhaegen F. First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric modulated arc therapy (VMAT). Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Vestergaard A, Sondergaard J, Petersen JB, Hoyer M, Muren LP. A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol 2010;49:1069–76.
   PubMed Web of Science ®Google Scholar
• Hoogeman M. A margin-of-the-day online-adaptive IMRT strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: A dosimetric evaluation. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Tuomikoski L. Implementation of adaptive radiation therapy for urinary bladder carcinoma: Imaging, planning and image guidance. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Wright P, Redpath AT, Hoyer M, Muren LP. A method to individualize adaptive planning target volumes for deformable targets. Phys Med Biol 2009;54:7121–33.
   PubMed Web of Science ®Google Scholar
• Potter R, Georg P, Dimopoulos JCA, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116–23.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Georg D, Potter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol 2010;20:121–9.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JCA, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012;103:113–22.
   PubMed Web of Science ®Google Scholar
• Lindegaard J. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;(this issue).
   Web of Science ®Google Scholar
• Hoeben B. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 2013;(this issue).
   PubMed Web of Science ®Google Scholar
• Carvalho S. Prognostic value of metabolic metrics extracted from baseline PET images in NSCLC. Acta Oncol 2013; (this issue).
   Web of Science ®Google Scholar